EirGenix Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was TWD 211.45 million compared to TWD 361.57 million a year ago. Net loss was TWD 111.72 million compared to TWD 27.57 million a year ago. Basic loss per share from continuing operations was TWD 0.37 compared to TWD 0.09 a year ago. Diluted loss per share from continuing operations was TWD 0.37 compared to TWD 0.09 a year ago.
For the nine months, sales was TWD 566.09 million compared to TWD 1,059.71 million a year ago. Net loss was TWD 509.27 million compared to TWD 7.3 million a year ago. Basic loss per share from continuing operations was TWD 1.67 compared to TWD 0.02 a year ago. Diluted loss per share from continuing operations was TWD 1.67 compared to TWD 0.02 a year ago.